Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Devon Clark"'
Autor:
Ryan Homes, Devon Clark, Sina Moridzadeh, Danijel Tosovic, Wolbert Van den Hoorn, Kylie Tucker, Mark Midwinter
Publikováno v:
Sensors, Vol 23, Iss 1, p 537 (2023)
Examination of gait patterns has been used to determine severity, intervention triage and prognostic measures for many health conditions. Methods that generate detailed gait data for clinical use are typically logistically constrained to a formal gai
Externí odkaz:
https://doaj.org/article/2b617ddd11af4d7bbbeef14b450e0bc4
Autor:
Ryan, Homes, Devon, Clark, Sina, Moridzadeh, Danijel, Tosovic, Wolbert, Van den Hoorn, Kylie, Tucker, Mark, Midwinter
Publikováno v:
Sensors (Basel, Switzerland). 23(1)
Examination of gait patterns has been used to determine severity, intervention triage and prognostic measures for many health conditions. Methods that generate detailed gait data for clinical use are typically logistically constrained to a formal gai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::816e9a1b1175870459204419e6d62647
https://pubmed.ncbi.nlm.nih.gov/36617135
https://pubmed.ncbi.nlm.nih.gov/36617135
Autor:
Sarah Williams, Surgeons, Nyc, Ny, Usa, Devon Clark, Caitlin Conyngham, Linden Lalley-Chareczko, Philadelphia Fight, Philadelphia, Pa, Usa, Sahana Jayaraman, Helen C. Koenig
Publikováno v:
HIV/AIDS Research and Treatment – Open Journal. 6:10-21
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ed575dcb5c36cfa1fe75bcb3d670017
https://doi.org/10.17140/hartoj-6-130
https://doi.org/10.17140/hartoj-6-130
Autor:
Lane DiFlavis, Linden Lalley-Chareczko, Helen C. Koenig, Rachel A Nahan, Michael T Ramos, Rose Cantor, Devon Clark, Gregory S. Troutman, Lindsay B. Young
Publikováno v:
International journal of STDAIDS. 31(5)
Pre-exposure prophylaxis (PrEP) with tenofovir disoproxil fumarate (TDF)/emtricitabine is 99% effective in preventing HIV when taken daily. Young men/transgender women of color who have sex with men are the most at risk to become infected with HIV, w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a699882b1a6b2542efa1fd91f51adafa
https://pubmed.ncbi.nlm.nih.gov/32208815
https://pubmed.ncbi.nlm.nih.gov/32208815
Autor:
Linden Lalley-Chareczko, Devon Clark, Caitlin Conyngham, Ganesh S. Moorthy, Helen C Koenig, Karam Mounzer, Athena F. Zuppa
Publikováno v:
Journal of acquired immune deficiency syndromes (1999). 79(2)
BACKGROUND Pre-exposure prophylaxis (PrEP) for HIV prevention with daily tenofovir and emtricitabine is effective when taken consistently. Currently, there is no objective way to monitor PrEP adherence. Urine has been shown to be highly correlated wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4dbb3669cf7f8d6d1fa4add4150daebb
https://pubmed.ncbi.nlm.nih.gov/29905593
https://pubmed.ncbi.nlm.nih.gov/29905593
Autor:
Helen C. Koenig, Devon Clark, Caitlin Conyngham, Ganesh S. Moorthy, Linden Lalley-Chareczko, Athena F. Zuppa, Karam Mounzer
Publikováno v:
Antiviral Therapy. 22:639-641
Emtricitabine/tenofovir disoproxil fumarate (FTC/TDF; Truvada®) given as pre-exposure prophylaxis (PrEP) successfully blocks HIV when taken once daily prior to potential HIV exposure. A 22-year-old male reported difficulty swallowing FTC/TDF for PrE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6a796f7d2806ff07ad3596b4829efe73
https://doi.org/10.3851/imp3151
https://doi.org/10.3851/imp3151
Autor:
Linden, Lalley-Chareczko, Devon, Clark, Athena F, Zuppa, Ganesh, Moorthy, Caitlin, Conyngham, Karam, Mounzer, Helen, Koenig
Publikováno v:
Antiviral therapy. 22(7)
Emtricitabine/tenofovir disoproxil fumarate (FTC/TDF; Truvada
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f2b290cd7888585ffa2cf76d9fa8e6f9
https://pubmed.ncbi.nlm.nih.gov/28260694
https://pubmed.ncbi.nlm.nih.gov/28260694